BDTX FY 2020 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

$125M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$70M

Net Income

-$67M

EPS (Diluted)

$-2.04

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$330M

Total Liabilities

$22M

Stockholders' Equity

$308M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$47,000	+100.0%
Operating Income	-$70M	-$9M	-681.3%
Net Income	-$67M	-$35M	-90.7%